J Korean Med Sci.  2010 May;25(5):746-751. 10.3346/jkms.2010.25.5.746.

Effects of Adipose-derived Stromal Cells and of their Extract on Wound Healing in a Mouse Model

Affiliations
  • 1Department of Plastic Surgery, College of Medicine, The Catholic University of Korea, Seoul, Korea. psyg@catholic.ac.kr

Abstract

In this study, the authors investigated the effects of adipose-derived stromal cells (ADSCs) and of their extract on wound healing. After creating wound healing splint model on the backs of mice, ADSCs and their extract were applied. Wound healing rates were calculated at 3, 5, 7, 10, and 14 days after the wounding, and tissues were harvested at 7 and 14 days for histological analysis. Wound healing rates were significantly higher at 7, 10, and 14 days in the cell group than in the control, but in the cell extract group wound healing rates were significantly decreased (P<0.05). Histological scores and capillary densities in the cell group were significantly higher at 2 weeks (P<0.05). In the cell group, thick inflammatory cell infiltration and many capillaries were observed at 1 week, and thick epithelium and numerous large capillaries were observed at 2 weeks. The present study suggests that ADSCs accelerate wound healing as known, and the effects of ADSCs on wound healing may be due to replacing insufficient cells by differentiation of ADSCs in the wound and secreting growth factors by differentiated cells, and not due to the effect of factors within ADSCs.

Keyword

Adipose-derived Stromal Cell; Cell Extract; Wound Healing

MeSH Terms

Adipocytes/*transplantation
Animals
Cells, Cultured
*Disease Models, Animal
Humans
Male
Mice
Mice, Inbred BALB C
Stem Cell Transplantation/*methods
Treatment Outcome
Wound Healing/*physiology
Wounds, Penetrating/*pathology/*surgery

Figure

  • Fig. 1 Two 6-mm circular full-thickness skin defects on the back of mouse with silicone rings.

  • Fig. 2 Changes of wound healing rates of the control, the cell, and the cell extract groups at 3, 5, 7, 10, and 14 days after wounding. *P<0.05 compared to control; †P<0.05 compared to the cell group; ‡P<0.05 compared to the cell extract group.

  • Fig. 3 Histological scores of wound in the control, the cell group, and the cell extract groups at 1 and 2 weeks after wounding. *P<0.05 compared to control and the cell extract group.

  • Fig. 4 Micrographs of wound bed and wound margin in each group at 1 and 2 weeks after wounding (H&E stain, 40). Wound edges are indicated by arrows. At 1 week after wounding, the control group shows thin granulation tissue containing many neutrophils and lymphocytes (A), the cell group shows thick inflammatory cell infiltrations with many capillaries (B), and the cell extract group has more granulation tissues than in the control group (C). At 2 weeks after wounding, the control group shows thick granulation tissues with little re-epithelialization (D), the cell group shows slightly thicker epithelium and greater granulation tissue (E), and the cell extract group shows less re-epithelization and granulation tissue than in the cell group at 2 weeks (F).

  • Fig. 5 Micrographs of wound bed and wound margin in each group at 1 and 2 weeks after wounding (Immunohistochemical staining for CD31, ×100). Capillaries with endothelial cells are stained brown (thin arrows). Wound edges are indicated by thick arrows. At 1 week, some small numbers of capillaries are observed in granulation tissues in the control group (A) and the cell extract group (C), but large numbers of capillaries are observed in the cell group (B). At 2 weeks after wounding, increased capillary development is noted in the control group (D), the cell group (E), and the cell extract groups (F). Particularly, in the cell group numerous larger capillaries are observed in comparison with other groups.

  • Fig. 6 Capillary densities in wounds of the control, cell group, and cell extract group at 1 and 2 weeks after wounding. *P<0.05 compared to the control and cell extract groups.


Reference

1. Martin P. Wound healing-aiming for perfect skin regeneration. Science. 1997. 276:75–81.
Article
2. Falanga V. Wound healing and its impairment in the diabetic foot. Lancet. 2005. 366:1736–1743.
Article
3. Zuk PA, Zhu M, Ashjian P, De Ugarte DA, Huang JI, Mizuno H, Alfonso ZC, Fraser JK, Benhaim P, Hedrick MH. Human adipose tissue is a source of multipotent stem cells. Mol Biol Cell. 2002. 13:4279–4295.
Article
4. De Ugarte DA, Morizono K, Elbarbary A, Alfonso Z, Zuk PA, Zhu M, Dragoo JL, Ashjian P, Thomas B, Benhaim P, Chen I, Fraser J, Hedrick MH. Comparison of multi-lineage cells from human adipose tissue and bone marrow. Cells Tissues Organs. 2003. 174:101–109.
Article
5. Izadpanah R, Trygg C, Patel B, Kriedt C, Dufour J, Gimble JM, Bunnell BA. Biologic properties of mesenchymal stem cells derived from bone marrow and adipose tissue. J Cell Biochem. 2006. 99:1285–1297.
Article
6. Wu Y, Chen L, Scott PG, Tredget EE. Mesenchymal stem cells enhance wound healing through differentiation and angiogenesis. Stem Cells. 2007. 25:2648–2659.
Article
7. Kim WS, Park BS, Sung JH, Yang JM, Park SB, Kwak SJ, Park JS. Wound healing effect of adipose-derived stem cells: a critical role of secretory factors on human dermal fibroblasts. J Dermatol Sci. 2007. 48:15–24.
Article
8. Galiano RD, Michaels J, Dobryansky M, Levine JP, Gurtner GC. Quantitative and reproducible murine model of excisional wound healing. Wound Repair Regen. 2004. 12:485–492.
Article
9. Jacobi J, Jang JJ, Sundram U, Dayoub H, Fajardo LF, Cooke JP. Nicotine accelerates angiogenesis and wound healing in genetically diabetic mice. Am J Pathol. 2002. 161:97–104.
Article
10. Yoon YS, Murayama T, Gravereaux E, Tkebuchava T, Silver M, Curry C, Wecker A, Kirchmair R, Hu CS, Kearney M, Ashare A, Jackson DG, Kubo H, Isner JM, Losordo DW. Vegf-c gene therapy augments postnatal lymphangiogenesis and ameliorates secondary lymphedema. J Clin Invest. 2003. 111:717–725.
Article
11. Badiavas EV, Abedi M, Butmarc J, Falanga V, Quesenberry P. Participation of bone marrow derived cells in cutaneous wound healing. J Cell Physiol. 2003. 196:245–250.
Article
12. Nakagawa H, Akita S, Fukui M, Fujii T, Akino K. Human mesenchymal stem cells successfully improve skin-substitute wound healing. Br J Dermatol. 2005. 153:29–36.
Article
13. Gharaee-Kermani M, Phan SH. Role of cytokines and cytokine therapy in wound healing and fibrotic diseases. Curr Pharm Des. 2001. 7:1083–1103.
14. Gaustad KG, Boquest AC, Anderson BE, Gerdes AM, Collas P. Differentiation of human adipose tissue stem cells using extracts of rat cardiomyocytes. Biochem Biophys Res Commun. 2004. 314:420–427.
Article
Full Text Links
  • JKMS
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr